Pharmicell (Korea) Market Value
| 005690 Stock | 9,080 50.00 0.55% |
| Symbol | Pharmicell |
Pharmicell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmicell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmicell.
| 11/25/2024 |
| 01/24/2025 |
If you would invest 0.00 in Pharmicell on November 25, 2024 and sell it all today you would earn a total of 0.00 from holding Pharmicell or generate 0.0% return on investment in Pharmicell over 60 days. Pharmicell is related to or competes with CU Medical, Global Standard, Adaptive Plasma, Woori Technology, NewFlex Technology, Guyoung Technology, and Dongwoon Anatech. More
Pharmicell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmicell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmicell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.19 | |||
| Information Ratio | 0.2199 | |||
| Maximum Drawdown | 18.58 | |||
| Value At Risk | (5.14) | |||
| Potential Upside | 9.15 |
Pharmicell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmicell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmicell's standard deviation. In reality, there are many statistical measures that can use Pharmicell historical prices to predict the future Pharmicell's volatility.| Risk Adjusted Performance | 0.2054 | |||
| Jensen Alpha | 0.9164 | |||
| Total Risk Alpha | 0.7217 | |||
| Sortino Ratio | 0.2687 | |||
| Treynor Ratio | (1.68) |
Pharmicell Backtested Returns
Pharmicell is very steady given 3 months investment horizon. Pharmicell maintains Sharpe Ratio (i.e., Efficiency) of 0.27, which implies the firm had a 0.27 % return per unit of risk over the last 3 months. We were able to analyze thirty different technical indicators, which can help you to evaluate if expected returns of 1.05% are justified by taking the suggested risk. Use Pharmicell Semi Deviation of 2.42, coefficient of variation of 430.57, and Risk Adjusted Performance of 0.2054 to evaluate company specific risk that cannot be diversified away. Pharmicell holds a performance score of 21 on a scale of zero to a hundred. The company holds a Beta of -0.53, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pharmicell are expected to decrease at a much lower rate. During the bear market, Pharmicell is likely to outperform the market. Use Pharmicell market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to analyze future returns on Pharmicell.
Auto-correlation | 0.20 |
Weak predictability
Pharmicell has weak predictability. Overlapping area represents the amount of predictability between Pharmicell time series from 25th of November 2024 to 25th of December 2024 and 25th of December 2024 to 24th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmicell price movement. The serial correlation of 0.2 indicates that over 20.0% of current Pharmicell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 132.9 K |
Pharmicell lagged returns against current returns
Autocorrelation, which is Pharmicell stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharmicell's stock expected returns. We can calculate the autocorrelation of Pharmicell returns to help us make a trade decision. For example, suppose you find that Pharmicell has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharmicell regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharmicell stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharmicell stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharmicell stock over time.
Current vs Lagged Prices |
| Timeline |
Pharmicell Lagged Returns
When evaluating Pharmicell's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharmicell stock have on its future price. Pharmicell autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharmicell autocorrelation shows the relationship between Pharmicell stock current value and its past values and can show if there is a momentum factor associated with investing in Pharmicell.
Regressed Prices |
| Timeline |
Pair Trading with Pharmicell
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pharmicell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmicell will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Pharmicell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharmicell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharmicell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharmicell to buy it.
The correlation of Pharmicell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pharmicell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pharmicell moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pharmicell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Pharmicell Stock
Pharmicell financial ratios help investors to determine whether Pharmicell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmicell with respect to the benefits of owning Pharmicell security.